Stock Price & Analysis

The S1 support level for TMCI Stock is $7.53 ,The R1 resistant level for TMCI Stock is $9.5.

As of the end of day on 2025-01-24, the price of TMCI Stock was $9.185.

The target price for TMCI Stock according to analyst rating is 9.28, with the highest price target at 14.50 and the lowest at 7.50. Analysts have a Hold rating on TMCI Stock overall.

The market cap of TMCI is $573.4M.

Treace Medical Concepts, Inc. is a medical technology company. The Company’s Lapiplasty three-dimensional (3D) Bunion Correction System is a combination of instruments, implants and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. The Lapiplasty System combines its novel surgical approach, the Lapiplasty Procedure, with its procedural instrumentation and single-use implant kits. The Company is also providing Adductoplasty Midfoot Correction System, designed for reproducible correction of the midfoot to provide further support to hallux valgus patients. The Lapiplasty and Adductoplasty Systems are comprised of single-use implant kits and reusable instrument trays. The Company also commercialized new products that address ancillary surgical procedures performed routinely in connection with the Lapiplasty Procedure.

TMCI has a total of 516 employees.